These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20805522)

  • 41. Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.
    Domínguez-Vivero C; Wu L; Lee S; Manoochehri M; Cines S; Brickman AM; Rizvi B; Chesebro A; Gazes Y; Fallon E; Lynch T; Heidebrink JL; Paulson H; Goldman JS; Huey E; Cosentino S
    J Alzheimers Dis; 2020; 75(2):595-606. PubMed ID: 32310161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single voxel magnetic resonance spectroscopy at 3 Tesla in a memory disorders clinic: early right hippocampal NAA/Cr loss in mildly impaired subjects.
    Caserta MT; Ragin A; Hermida AP; Ahrens RJ; Wise L
    Psychiatry Res; 2008 Nov; 164(2):154-9. PubMed ID: 18930637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
    Rademakers R; Cruts M; van Broeckhoven C
    Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
    Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterizing the Clinical Features and Atrophy Patterns of
    Young AL; Bocchetta M; Russell LL; Convery RS; Peakman G; Todd E; Cash DM; Greaves CV; van Swieten J; Jiskoot L; Seelaar H; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Sorbi S; Williams SCR; Alexander DC; Rohrer JD;
    Neurology; 2021 Aug; 97(9):e941-e952. PubMed ID: 34158384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurometabolic Remodeling in Chronic Hiv Infection: a Five-Year Follow-up Multi-Voxel Mrs Study.
    Boban J; Thurnher MM; Brkic S; Lendak D; Bugarski Ignjatovic V; Todorovic A; Kozic D
    Sci Rep; 2019 Dec; 9(1):19799. PubMed ID: 31875001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.
    Wu L; Liu J; Feng X; Dong J; Qin W; Liu Y; Wang J; Lu J; Chen K; Wang Y; Jia J
    J Alzheimers Dis; 2018; 61(2):613-618. PubMed ID: 29226866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia.
    Sogorb-Esteve A; Nilsson J; Swift IJ; Heller C; Bocchetta M; Russell LL; Peakman G; Convery RS; van Swieten JC; Seelaar H; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Tartaglia MC; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; Santana I; Butler CR; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Sorbi S; Le Ber I; Pasquier F; Gobom J; Brinkmalm A; Blennow K; Zetterberg H; Rohrer JD;
    Alzheimers Res Ther; 2022 Aug; 14(1):118. PubMed ID: 36045450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anterior to posterior hippocampal MRS metabolite difference is mainly a partial volume effect.
    Starck G; Vkhoff-Baaz B; Ljungberg M; Malmgren K; Forssell-Aronsson E; Jönsson L; Ekholm S
    Acta Radiol; 2010 Apr; 51(3):351-9. PubMed ID: 20201639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection and application of neurochemical profile by multiple regional
    Guan J; Rong Y; Wen Y; Wu H; Qin H; Zhang Q; Chen W
    Brain Behav; 2017 Sep; 7(9):e00792. PubMed ID: 28948086
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Magnetic Resonance Spectroscopy (MRS) in Alzheimer's Disease.
    Sheikh-Bahaei N; Chen M; Pappas I
    Methods Mol Biol; 2024; 2785():115-142. PubMed ID: 38427192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD.
    Korn L; Speicher AM; Schroeter CB; Gola L; Kaehne T; Engler A; Disse P; Fernández-Orth J; Csatári J; Naumann M; Seebohm G; Meuth SG; Schöler HR; Wiendl H; Kovac S; Pawlowski M
    Redox Biol; 2023 Feb; 59():102597. PubMed ID: 36599286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Proton magnetic resonance spectroscopy of prefrontal lobe and thalamus in schizophrenics: correlation with clinical characteristics].
    Gan JL; Duan HF; Yang JM; Shi ZJ; Zhang DW; Jiang ZK; Gao CY; Wang ZJ
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(43):3034-9. PubMed ID: 22333054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short echo time single-voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis.
    Woermann FG; McLean MA; Bartlett PA; Parker GJ; Barker GJ; Duncan JS
    Ann Neurol; 1999 Mar; 45(3):369-76. PubMed ID: 10072052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Application of multi-voxel proton magnetic resonance spectroscopy in different hippocampal regions of normal cognitive people].
    Dai Z; Chen F; Zhang B; Yao L; Dong C; Xu Y; Zhu B; Zhang X; Li M; Wang H
    Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(41):3234-8. PubMed ID: 25604224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
    Martínez-Bisbal MC; Arana E; Martí-Bonmatí L; Martínez-Granados B; Celda B
    Radiologia; 2006; 48(5):301-7. PubMed ID: 17168239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study.
    van der Ende EL; Meeter LH; Poos JM; Panman JL; Jiskoot LC; Dopper EGP; Papma JM; de Jong FJ; Verberk IMW; Teunissen C; Rizopoulos D; Heller C; Convery RS; Moore KM; Bocchetta M; Neason M; Cash DM; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Carmela Tartaglia M; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler C; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Frisoni GB; Cappa S; Pijnenburg YAL; Rohrer JD; van Swieten JC;
    Lancet Neurol; 2019 Dec; 18(12):1103-1111. PubMed ID: 31701893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characteristic early changes of Glu and Cho in brain regions affected by different types of subjective cognitive decline and their clinical significance.
    Zeng Z; He J; Yao T
    Medicine (Baltimore); 2023 Dec; 102(49):e36457. PubMed ID: 38065860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN.
    Whitwell JL; Jack CR; Boeve BF; Senjem ML; Baker M; Rademakers R; Ivnik RJ; Knopman DS; Wszolek ZK; Petersen RC; Josephs KA
    Neurology; 2009 Mar; 72(9):813-20. PubMed ID: 19255408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.